Search hospitals > West Virginia > Charleston
Novartis Investigative Site
Claim this profileCharleston, West Virginia 25304
Conducts research for Chronic Obstructive Pulmonary Disease
Conducts research for Obstructive Lung Diseases
Conducts research for Lung Disease
Conducts research for Arthritis
Conducts research for Heart Failure
80 reported clinical trials
1 medical researcher
Summary
Novartis Investigative Site is a medical facility located in Charleston, West Virginia. This center is recognized for care of Chronic Obstructive Pulmonary Disease, Obstructive Lung Diseases, Lung Disease, Arthritis, Heart Failure and other specialties. Novartis Investigative Site is involved with conducting 80 clinical trials across 73 conditions. There are 1 research doctors associated with this hospital, such as Shayla Bergmann.Top PIs
Clinical Trials running at Novartis Investigative Site
Cardiovascular Disease
Acute Coronary Syndrome
Syndrome
Sickle Cell Disease
Sickle Cell Anemia
Atherosclerosis
Inclisiran
for Cardiovascular Disease
This trial is testing inclisiran, an injectable drug, on people with heart disease who are already on strong cholesterol-lowering medications. The goal is to see if inclisiran can further reduce the risk of heart attacks and strokes by lowering bad cholesterol levels. Participants will receive the injection periodically. Inclisiran works by significantly reducing bad cholesterol levels.
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Charleston, West Virginia. This center is recognized for care of Chronic Obstructive Pulmonary Disease, Obstructive Lung Diseases, Lung Disease, Arthritis, Heart Failure and other specialties. Novartis Investigative Site is involved with conducting 80 clinical trials across 73 conditions. There are 1 research doctors associated with this hospital, such as Shayla Bergmann.